Drug Discovery and Design Center Shanghai Institute of Materia Medica Chinese Academy of Sciences Shanghai 201203 China Shanghai Key Laboratory of Chemical Biology School of Pharmacy East China University of Science and Technology Shanghai 200237 China;
Division of Anti-Tumor Pharmacology State Key Laboratory of Drug Research Shanghai Institute of Materia Medica Chinese Academy of Sciences Shanghai 201203 China;
Drug Discovery and Design Center Shanghai Institute of Materia Medica Chinese Academy of Sciences Shanghai 201203 China;
Division of Anti-Tumor Pharmacology State Key Laboratory of Drug Research Shang;
机译:噻唑烷-2,4-二酮类似物作为胰岛素样生长因子-1受体(IGF-1R)抑制剂的发现和SAR通过分层虚拟筛选
机译:胰岛素样生长因子1受体(IGF-1R)激酶抑制剂:一系列3-(6-(4-取代-哌嗪-1-基)-4-甲基-1H-苯并咪唑-2-基)的SAR -1H-吡啶-2-一。
机译:胰岛素样生长因子-1受体(IGF-1R)的有效,选择性,口服,生物有效的新型2-(Pyrazol-4-ylamino)-嘧啶抑制剂的发现。
机译:噻唑烷-2,4-二酮类似物的发现和SAR作为胰岛素样生长因子-1受体(IGF-1R)抑制剂,通过分层虚拟筛选
机译:开发了一种评估乳腺癌中胰岛素受体和胰岛素样生长因子-1受体同型二聚体和杂合受体的可靠方法。
机译:胰岛素样生长因子-1受体(IGF-1R)作为非小细胞肺癌对酪氨酸激酶抑制剂吉非替尼耐药的生物标志物
机译:通过分层虚拟筛选发现噻唑烷-2,4-二酮类似物作为胰岛素样生长因子-1受体(IGF-1R)抑制剂